References
- Buschke A. Ueber scleroedem. Berl Klin Wochenschr 1902;39:955–957.
- Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am 2008;34:199–220.
- Harati A, Brockmeyer NH, Altmeyer P, et al. Skin disorders in association with monoclonal gammopathies. Eur J Med Res 2005;10:93–104.
- Ulmer A, Schaumburg-Lever G, Bauer J, et al. Scleredema adultorum Buschke. Case report and review of the literature [in German]. Hautarzt 1998;49:48–54.
- Varga J, Gotta S, Li L, et al. Scleredema adultorum: case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro. Br J Dermatol 1995;132:992–999.
- Graff R. Scleredema adultorum. Arch Dermatol 1968;98:319–320.
- Rho YW, Suhr KB, Lee JH, et al. A clinical observation of scleredema adultorum and its relationship to diabetes. J Dermatol 1998;25:103–107.
- Morais P, Almeida M, Santos P, et al. Scleredema of Buschke following Mycoplasma pneumoniae respiratory infection. Int J Dermatol 2011;50:454–457.
- Bowen AR, Smith L, Zone JJ. Scleredema adultorum of Buschke treated with radiation. Arch Dermatol 2003;139:780–784.
- Dziadzio M, Anastassiades CP, Hawkins PN, et al. From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature. Clin Rheumatol 2006;25:3–15.
- Ataergin S, Arpaci F, Demiriz M, et al. Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of scleromyxedema. Am J Clin Dermatol 2008;9:271–273.
- Migkou M, Gkotzamanidou M, Terpos E, et al. Response to bortezomib of a patient with scleromyxedema refractory to other therapies. Leuk Res 2011;35:e209–e211.
- Fett NM, Toporcer MB, Dalmau J, et al. Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib. Am J Hematol 2011;86:893–896.
- Cañueto J, Labrador J, Román C, et al. The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights. Eur J Haematol 2012;88:450–454.
- Yeung CK, Loong F, Kwong YL. Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone. Br J Haematol 2012;157:411.